ConductScience.org, home

Paper28246014

Montelukast inhibits oxidized low-density lipoproteins (ox-LDL) induced vascular endothelial attachment: An implication for the treatment of atherosclerosis.

Di X and 2 others. Biochem Biophys Res Commun, 2017. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. Montelukast inhibits oxidized low-density lipoproteins (ox-LDL) induced vascular endothelial attachment: An implication for the treatment of atherosclerosis. Papers, record 28246014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28246014

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Montelukast inhibits oxidized low-density lipoproteins (ox-LDL) induced vascular endothelial attachment: An implication for the treatment of atherosclerosis.
PubMed
Journal
Biochem Biophys Res Commun
PubMed
Year
2017
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
1.25
iCite
Revised in PubMed
2022-04-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Di XXiuhua
2Tang XXuelu
3Di XXiuting

Source PubMed

Download CSV of authors

Topics25

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcetatesMajor topic
Endothelium, VascularMajor topic
Lipoproteins, LDLMajor topic
MonocytesMajor topic
QuinolinesMajor topic
Anti-Asthmatic Agents
Atherosclerosis
Blotting, Western
Cell Adhesion
Cell Line, Tumor
Cells, Cultured
Cyclopropanes
Dose-Response Relationship, Drug
E-Selectin
Gene Expression
Human Umbilical Vein Endothelial Cells
Humans
Kruppel-Like Transcription Factors
Mitogen-Activated Protein Kinase 7
Molecular Structure
Protective Agents
RNA Interference
Reverse Transcriptase Polymerase Chain Reaction
Sulfides
Vascular Cell Adhesion Molecule-1

Source PubMed

Download CSV of topics

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
41680878Montelukast suppresses NLRP3 inflammasome activation as a potential prophylactic agent against gout arthritis flares.J Inflamm (Lond)2026https://conductscience.org/library/papers/41680878PubMed
41034674Evaluating the role of montelukast on doxorubicin-induced cardiotoxicity in breast cancer patients.Support Care Cancer2025https://conductscience.org/library/papers/41034674PubMed
40418318Pharmacological and toxicological roles of Kruppel-like factors (KLFs) in the cardiovascular system: a review.Mol Biol Rep2025https://conductscience.org/library/papers/40418318PubMed
39358316Cysteinyl Leukotriene Receptor Antagonism by Montelukast to Treat Visual Deficits.J Ocul Pharmacol Ther2024https://conductscience.org/library/papers/39358316PubMed
38337010Montelukast, an available and safe anti-asthmatic drug, prevents maladaptive remodelling and maintains cardiac functionality following myocardial infarction.Sci Rep2024https://conductscience.org/library/papers/38337010PubMed
37163659Endothelial mechanobiology in atherosclerosis.Cardiovasc Res2023https://conductscience.org/library/papers/37163659PubMed
36984888Participation of Krüppel-like Factors in Atherogenesis.Metabolites2023https://conductscience.org/library/papers/36984888PubMed
36429069Role of Long Noncoding RNAs in the Regulation of Cellular Immune Response and Inflammatory Diseases.Cells2022https://conductscience.org/library/papers/36429069PubMed
35264962Astragaloside IV Relieves Atherosclerosis and Hepatic Steatosis via MAPK/NF-κB Signaling Pathway in LDLR-/- Mice.Front Pharmacol2022https://conductscience.org/library/papers/35264962PubMed
35203463The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy.Biomedicines2022https://conductscience.org/library/papers/35203463PubMed
34950025Guanxinkang Decoction Attenuates the Inflammation in Atherosclerosis by Regulating Efferocytosis and MAPKs Signaling Pathway in LDLR-/- Mice and RAW264.7 Cells.Front Pharmacol2021https://conductscience.org/library/papers/34950025PubMed
34565285Montelukast attenuates interleukin IL-1β-induced oxidative stress and apoptosis in chondrocytes by inhibiting CYSLTR1 (Cysteinyl Leukotriene Receptor 1) and activating KLF2 (Kruppel Like Factor 2).Bioengineered2021https://conductscience.org/library/papers/34565285PubMed
34218304Comparative study evaluating antihistamine versus leukotriene receptor antagonist as adjuvant therapy for rheumatoid arthritis.Eur J Clin Pharmacol2021https://conductscience.org/library/papers/34218304PubMed
33519477Montelukast Use Decreases Cardiovascular Events in Asthmatics.Front Pharmacol2020https://conductscience.org/library/papers/33519477PubMed
33392263The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic.Front Mol Biosci2020https://conductscience.org/library/papers/33392263PubMed
32990894LncRNA OIP5-AS1 facilitates ox-LDL-induced endothelial cell injury through the miR-98-5p/HMGB1 axis.Mol Cell Biochem2021https://conductscience.org/library/papers/32990894PubMed
31865360
Oxidized Low Density Lipoprotein-Induced Atherogenic Response of Human Umbilical Vascular Endothelial Cells (HUVECs) was Protected by Atorvastatin by Regulating miR-26a-5p/Phosphatase and Tensin Homolog (PTEN).
Med Sci Monit2019https://conductscience.org/library/papers/31865360PubMed
31410121miR-125a-5p inhibits the expression of NLRP3 by targeting CCL4 in human vascular smooth muscle cells treated with ox-LDL.Exp Ther Med2019https://conductscience.org/library/papers/31410121PubMed
31277498Modulation of Nitric Oxide Synthases by Oxidized LDLs: Role in Vascular Inflammation and Atherosclerosis Development.Int J Mol Sci2019https://conductscience.org/library/papers/31277498PubMed
31263710Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Induces M2 Macrophage Polarization and Inhibits Murine Aortic Aneurysm Formation.Biomed Res Int2019https://conductscience.org/library/papers/31263710PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
KLF210365PubTator's text mininghttps://conductscience.org/library/genes/10365NCBI Gene
MAPK75598PubTator's text mininghttps://conductscience.org/library/genes/5598NCBI Gene
SELE6401PubTator's text mininghttps://conductscience.org/library/genes/6401NCBI Gene
VCAM17412PubTator's text mininghttps://conductscience.org/library/genes/7412NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28246014

GET https://conductscience.org/api/papers/v1/28246014/authors